Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
9.17
-0.50 (-5.17%)
At close: Feb 21, 2025, 4:00 PM
9.34
+0.17 (1.89%)
After-hours: Feb 21, 2025, 7:44 PM EST
TNXP Employees
Tonix Pharmaceuticals Holding had 103 employees as of December 31, 2023. The number of employees decreased by 14 or -11.97% compared to the previous year.
Employees
103
Change (1Y)
-14
Growth (1Y)
-11.97%
Revenue / Employee
$109,621
Profits / Employee
-$1,313,107
Market Cap
51.26M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
TNXP News
- 15 days ago - Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash - GlobeNewsWire
- 16 days ago - Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases - GlobeNewsWire
- 17 days ago - Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference - GlobeNewsWire
- 18 days ago - Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer - GlobeNewsWire
- 19 days ago - Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split - GlobeNewsWire
- 2 months ago - Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia - GlobeNewsWire
- 2 months ago - FDA accepts Tonix's NDA for non-opioid fibromyalgia drug TNX-102 SL - Invezz
- 2 months ago - Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia - GlobeNewsWire